Physician profile
Daniel E Gelb
NPI 1538107677
$40,405.73
in general payments reported to CMS, 2019-2025
9 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $12K · 2021: $5,070 · 2022: $4,999 · 2023: $2,420 · 2024: $4,546 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3,640 · Travel and Lodging: $2,131 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,639.60 |
| Travel and Lodging | $2,130.95 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Food and Beverage | $111.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $21,489.70 | 2019-2025 | Oracle |
| Synthes Gmbh | $11,895.43 | 2019-2024 | |
| Medical Device Business Services, INC. | $4,972.50 | 2020-2022 | |
| Centinel Spine, LLC | $1,492.06 | 2020 | |
| Stryker Corporation | $171.73 | 2019 | |
| Medtronic USA, INC. | $146.20 | 2019 | |
| Nuvasive, INC. | $111.72 | 2023 | Attrax, Magec Spinal Bracing and Distraction System, Tlif |
| Globus Medical, INC. | $79.25 | 2019-2020 | |
| Smith+Nephew, INC. | $47.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gelb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.